Postprandial activation of hemostatic factors: Role of dietary fatty acids

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 72, Issue 6, 2005, Pages 381-391

  Duttaroy, Asim K ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; FATTY ACID; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

CARDIOVASCULAR RISK; FAT INTAKE; GENDER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; LIPID COMPOSITION; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION;

EID: 20144382886     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.03.003     Document Type: Article

References (135)

1. M.U. Jakobsen, K. Overvad, J. Dyerberg, M. Schroll, and B.L. Heitmann Dietary fat and risk of coronary heart disease: possible effect modification by gender and age Am. J. Epidemiol. 160 2004 141 149
2. M. Lefevre, P.M. Kris-Etherton, G. Zhao, and R.P. Tracy Dietary fatty acids, hemostasis, and cardiovascular disease risk J. Am. Diet. Assoc. 104 2004 410 419
3. J.A. Jakubowski, N.G. Ardlie, F.J. Morgan, and C.N. Chesterman Further observations on the effects of dietary fatty-acid composition on platelet reactivity and blood-coagulation in man and the influence of methodology on findings Atherosclerosis 41 1982 285 294
4. V.L. Crawford, S.E. McNerlan, and R.W. Stout Seasonal changes in platelets, fibrinogen and factor VII in elderly people Age Ageing 32 2003 661 665
5. J.C. Hoak Stearic-acid, clotting, and thrombosis Am. J. Clin. Nutr. 60 1994 S1050 S1053
6. R. Knofler, T. Nakano, K. Nakajima, Y. Takada, and A. Takada Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro Thromb. Res. 78 1995 161 171
7. T.A. Sanders, T. de Grassi, J. Acharya, G.J. Miller, and S.E. Humphries Postprandial variations in fibrinolytic activity in middle-aged men are modulated by plasminogen activator inhibitor I 4G-675/5G genotype but not by the fat content of a meal Am. J. Clin. Nutr. 79 2004 577 581
8. A. Silveira Postprandial triglycerides and blood coagulation Exp.Clin. Endocrinol. Diabetes 109 2001 S527 S532
9. E.M. Bladbjerg, P. Marckmann, B. Sandstrom, and J. Jespersen Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet Thromb. Haemost. 71 1994 755 758
10. R. Freese, and M. Mutanen Postprandial changes in platelet-function and coagulation-factors after high-fat meals with different fatty-acid compositions Eur. J. Clin. Nutr. 49 1995 658 664
11. H.M. Roche, and M.J. Gibney The impact of postprandial lipemia in accelerating atherothrombosis J Cardiovasc. Risk 7 2000 317 324
12. M. Saigo, S. Abe, M. Ogawa, S. Biro, S. Minagoe, I. Maruyama, H. Toda, K. Kiyonaga, Y. Atsuchi, M. Tahara, K. Mawatari, and C. Tei Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction Thromb. Res. 100 2000 9 17
13. L.K. Summers, B.A. Fielding, V. Ilic, P.T. Quinlan, and K.N. Frayn The effect of triacylglycerol-fatty acid positional distribution on postprandial metabolism in subcutaneous adipose tissue Br.J. Nutr. 79 1998 141 147
14. C.M. Williams, P.A. Bateman, K.G. Jackson, and P. Yaqoob Dietary fatty acids and chylomicron synthesis and secretion Biochem. Soc. Trans. 32 2004 55 58
15. K.G. Mann Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk Arteriosclerosis 9 1989 783 784
16. P.M. Mannucci Polymorphisms in the factor VII gene and the risk of myocardial infarction N. Engl. J. Med. 344 2001 458 459
17. G.J. Miller, J.K. Cruickshank, L.J. Ellis, R.L. Thompson, H.C. Wilkes, Y. Stirling, K.A. Mitropoulos, J.V. Allison, T.E. Fox, and A.O. Walker Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor Atherosclerosis 78 1989 19 24
18. T.A. Sanders, F.R. Oakley, J.A. Cooper, and G.J. Miller Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects Am. J. Clin. Nutr. 73 2001 715 721
19. R.P. Tracy Diet and hemostatic factors Curr. Atheroscler. Rep. 1 1999 243 248
20. W. Koenig Haemostatic risk factors for cardiovascular diseases Eur. Heart J. 19 Suppl C 1998 C39 C43
21. F.M. Maggi, S. Raselli, L. Grigore, L. Redaelli, S. Fantappie, and A.L. Catapano Lipoprotein remnants and endothelial dysfunction in the postprandial phase J. Clin. Endocrinol. Metab. 89 2004 2946 2950
22. F. Karpe Mechanisms of postprandial hyperlipidaemia - Remnants and coronary artery disease Diabet. Med. 14 1997 S60 S66
23. M. Mukherjee, G. Dawson, K. Sembhi, and V.V. Kakkar Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis Thromb. Haemost. 76 1996 500 501
24. F.R. Oakley, T.A. Sanders, and G.J. Miller Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men Am. J. Clin. Nutr. 68 1998 1202 1207
25. T.G. Redgrave, D.R. Kodali, and D.M. Small The effect of triacyl-sn-glycerol structure on the metabolism of chylomicrons and triacylglycerol-rich emulsions in the rat J. Biol. Chem. 263 1988 5118 5123
26. T.A. Sanders, S.E. Berry, and G.J. Miller Influence of triacylglycerol structure on the postprandial response of factor VII to stearic acid-rich fats Am. J. Clin. Nutr. 77 2003 777 782
27. J.T. Snook, S. Park, G. Wardlaw, R. Jandacek, D. Palmquist, M.S. Lee, and J. Hoover Chylomicron fatty acid composition and serum lipid concentrations in subjects fed caprenin or palm oil palm kernel oil as the major dietary fat Nutr. Res. 16 1996 925 936
28. K.M. Yli-Jokipii, U.S. Schwab, R.L. Tahvonen, J.P. Kurvinen, H.M. Mykkanen, and H.P.T. Kallio Triacylglycerol molecular weight and to a lesser extent, fatty acid positional distribution, affect chylomicron triacylglycerol composition in women J. Nutr. 132 2002 924 929
29. A. Zampelas, C.M. Williams, L.M. Morgan, J. Wright, and P.T. Quinlan The effect of triacylglycerol fatty-acid positional distribution on postprandial plasma metabolite and hormone responses in normal adult men Br. J. Nutr. 71 1994 401 410
30. T.A. Sanders Dietary fat and postprandial lipids Curr. Atheroscler. Rep. 5 2003 445 451
31. E.J. Parks Recent findings in the study of postprandial lipemia Curr.Atheroscler.Rep. 3 2001 462 470
32. T. Tholstrup, G.J. Miller, A. Bysted, and B. Sandstrom Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men Am. J.Clin. Nutr. 77 2003 1125 1132
33. T.A. Sanders, G.J. Miller, T. de Grass, and N. Yahia Postprandial activation of coagulant factor VII by long-chain dietary fatty acids Thromb. Haemost. 76 1996 369 371
34. T. Tholstrup, P. Marckmann, J. Hermansen, G. Holmer, and B. Sandstrom Effect of modified dairy fat on fasting and postprandial haemostatic variables in healthy young men Br. J. Nutr. 82 1999 105 113
35. R. Wilson, K. Lyall, E.M. Millar, L. Smyth, C. Pearson, and R.A. Riemersma Do oxidized fatty acids activate coagulation factor VII during post-prandial lipemia in women? Thromb. Haemost. 89 2003 654 659
36. Y. Park, and W.S. Harris Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance J. Lipid Res. 44 2003 455 463
37. C.M. Williams Dietary interventions affecting chylomicron and chylomicron remnant clearance Atherosclerosis 141 1998 S87 S92
38. T. Tholstrup, B. Sandstrom, A. Bysted, and G. Holmer Effect of 6 dietary fatty acids on the postprandial lipid profile, plasma fatty acids, lipoprotein lipase, and cholesterol ester transfer activities in healthy young men Am. J. Clin. Nutr. 73 2001 198 208
39. R.E. Morton, and D.J. Greene Suppression of lipid transfer inhibitor protein activity by oleate - A novel mechanism of cholesteryl ester transfer protein regulation by plasma free fatty acids Arterioscl. Thromb. Vasc. Biol. 17 1997 3041 3048
40. H.C.F. Oliveira, and E.C.R. Quintao 'In vitro' cholesteryl ester bidirectional flow between high-density lipoproteins and triglyceride-rich emulsions: effects of particle concentration and composition, cholesteryl ester transfer activity and oleic acid J. Biochem. Biophys. Meth. 32 1996 45 57
41. F. Syeda, C. Senault, B. Delplanque, B. Le Roy, A. Thaminy, D. Gripois, M.F. Blouquit, A. Ruelland, F. Mendy, and C. Lutton Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men Nutr. Metab. Cardiovasc. Dis. 13 2003 28 36
42. J.E. Groener, E.M. van Ramshorst, M.B. Katan, R.P. Mensink, and A. van Tol Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects Atherosclerosis 87 1991 221 226
43. S. Jansen, J. Lopez-Miranda, P. Castro, F. Lopez-Segura, C. Marin, J.M. Ordovas, E. Paz, J. Jimenez-Pereperez, F. Fuentes, and F. Perez-Jimenez Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men Am. J. Clin. Nutr. 72 2000 36 41
44. H. Duez, J.C. Fruchart, and B. Staels PPARs in inflammation, atherosclerosis and thrombosis J. Cardiovasc. Risk 8 2001 187 194
45. C.S. Elangbam, R.D. Tyler, and R.M. Lightfoot Peroxisome proliferator-activated receptors in atherosclerosis and inflammation - an update Toxicol. Pathol. 29 2001 224 231
46. P.A. Grimaldi The roles of PPARs in adipocyte differentiation Prog. Lipid Res. 40 2001 269 281
47. S.A. Khan, and J.P.V. Heuvel Reviews: current topics - role of nuclear receptors in the regulation of gene expression by dietary fatty acids (Review) J. Nutr. Biochem. 14 2003 554 567
48. M. Ricote, A.F. Valledor, and C.K. Glass Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis Arterioscl. Thromb. Vasc. Biol 24 2004 230 239
49. H. Bays, and E.A. Stein Pharmacotherapy for dyslipidaemia - current therapies and future agents Expert Opin. Pharmacother. 4 2003 1901 1938
50. D. Lairon Nutritional and metabolic aspects of postprandial lipemia Reprod. Nutr. Dev. 36 1996 345 355
51. E.H. Temme, R.P. Mensink, and G. Hornstra Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects J. Lipid Res. 38 1997 1746 1754
52. A. Aro, M. Jauhiainen, R. Partanen, I. Salminen, and M. Mutanen Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein (a), and lipid transfer proteins in healthy subjects Am. J. Clin. Nutr. 65 1997 1419 1426
53. K.A. Hunter, L.C. Crosbie, G.W. Horgan, G.J. Miller, and A.K. Duttaroy Effect of diets rich in oleic acid, stearic acid and linoleic acid on postprandial haemostatic factors in young healthy men Br. J. Nutr. 86 2001 207 215
54. T. Tholstrup, B. Vessby, and B. Sandstrom Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men Eur. J. Clin. Nutr. 57 2003 735 742
55. C. Thomsen, O. Rasmussen, T. Lousen, J.J. Holst, S. Fenselau, J. Schrezenmeir, and K. Hermansen Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects Am. J. Clin. Nutr. 69 1999 1135 1143
56. K.A. Hunter, L.C. Crosbie, A. Weir, G.J. Miller, and A.K. Duttaroy A residential study comparing the effects of diets rich in stearic acid, oleic acid, and linoleic acid on fasting blood lipids, hemostatic variables and platelets in young healthy men J. Nutr. Biochem. 11 2000 408 416
57. F.D. Kelly, N.J. Mann, A.H. Turner, and A.J. Sinclair Stearic acid-rich diets do not increase thrombotic risk factors in healthy males Lipids 34 Suppl 1999 S199
58. F.D. Kelly, A.J. Sinclair, N.J. Mann, A.H. Turner, L. Abedin, and D. Li A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males Eur. J. Clin. Nutr. 55 2001 88 96
59. F.H. Mattson, and S.M. Grundy Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man J. Lipid Res. 26 1985 194 202
60. F. Lopez-Segura, F. Velasco, J. Lopez-Miranda, P. Castro, R. Lopez-Pedrera, A. Blanco, J. Jimenez-Pereperez, A. Torres, J. Trujillo, J.M. Ordovas, and F. Perez-Jimenez Monounsaturated fatty acid-enriched diet decreases plasma plasminogen activator inhibitor type 1 Arterioscl. Thromb. Vasc. Biol. 16 1996 82 88
61. N.M. de Roos, E.G. Schouten, and M.B. Katan Trans fatty acids, HDL-cholesterol, and cardiovascular disease. Effects of dietary changes on vascular reactivity Eur. J. Med. Res. 8 2003 355 357
62. V. Wijendran, and K.C. Hayes Dietary n-3 and n-6 fatty acid balance and cardiovascular health Ann. Rev. Nutr. 24 2004 597 615
63. H.M. Roche, and M.J. Gibney Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state Lipids 34 Suppl 1999 S259 S265
64. S. Khan, A.M. Minihane, P.J. Talmud, J.W. Wright, M.C. Murphy, C.M. Williams, and B.A. Griffin Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype J. Lipid Res. 43 2002 979 985
65. Y.E. Finnegan, A.M. Minihane, E.C. Leigh-Firbank, S. Kew, G.W. Meijer, R. Muggli, P.C. Calder, and C.M. Williams Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects Am. J. Clin. Nutr. 77 2003 783 795
66. K.A. Hunter, L.C. Crosbie, A. Weir, G.J. Miller, and A.K. Duttaroy The effects of structurally defined triglycerides of differing fatty acid composition on postprandial haemostasis in young, healthy men Atherosclerosis 142 1999 151 158
67. L. Mennen, M. de Maat, G. Meijer, P. Zock, D. Grobbee, F. Kok, C. Kluft, and E. Schouten Factor VIIa response to a fat-rich meal does not depend on fatty acid composition - a randomized controlled trial Arterioscl. Thromb. Vasc. Biol. 18 1998 599 603
68. G.J. Miller Effects of diet composition on coagulation pathways Am. J. Clin. Nutr. 67 1998 542S 545S
69. V.V. Salomaa, I. Salminen, V. Rasi, E. Vahtera, A. Aro, and G. Myllyla Association of the fatty acid composition of serum phospholipids with hemostatic factors Arterioscl. Thromb. Vasc. Biol. 17 1997 809 813
70. H. Mu, and C.E. Hoy The digestion of dietary triacylglycerols Prog. Lipid Res. 43 2004 105 133
71. K. Yli-Jokipii, H. Kallio, U. Schwab, H. Mykkanen, J.P. Kurvinen, M.J. Savolainen, and R. Tahvonen Effects of palm oil and transesterified palm oil on chylomicron and VLDL triacylglycerol structures and postprandial lipid response J. Lipid Res. 42 2001 1618 1625
72. K.M. Yli-Jokipii, U.S. Schwab, R.L. Tahvonen, J.P. Kurvinen, H.M. Mykkanen, and H.P. Kallio Chylomicron and VLDL TAG structures and postprandial lipid response induced by lard and modified lard Lipids 38 2003 693 703
73. C.D. Byrne, N.J. Wareham, N.D. Martensz, S.E. Humphries, J.C. Metcalfe, and D.J. Grainger Increased PAI activity and PAI-1 antigen occurring with an oral fat load: associations with PAI-1 genotype and plasma active TGF-beta levels Atherosclerosis 140 1998 45 53
74. L. Niskanen, U.S. Schwab, E.S. Sarkkinen, T. Krusius, E. Vahtera, and M.I. Uusitupa Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance Metabolism 46 1997 666 672
75. M. Weintraub, G. Charach, and I. Grosskopf Disturbances in dietary fat metabolism and their role in the development of atherosclerosis Biomed. Pharmacotherap. 51 1997 311 313
76. T.W. Meade, V. Ruddock, Y. Stirling, R. Chakrabarti, and G.J. Miller Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 342 1993 1076 1079
77. B.B. Duncan, M.I. Schmidt, S. Offenbacher, K.K. Wu, P.J. Savage, and G. Heiss Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study Diabetes Care 22 1999 767 772
78. R. Junker, J. Heinrich, H. Schulte, M. Erren, and G. Assmann Hemostasis in normotensive and hypertensive men: results of the PROCAM study. The prospective cardiovascular Munster study J. Hypertens. 16 1998 917 923
79. A.J. Lee, F.G. Fowkes, G.D. Lowe, J.M. Connor, and A. Rumley Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study Thromb. Haemost. 81 1999 553 560
80. C. Hoffman, A. Shah, M. Sodums, and M.B. Hultin Factor VII activity state in coronary artery disease J. Lab. Clin. Med. 111 1988 475 481
81. R. Junker, J. Heinrich, H. Schulte, L.J. van de, and G. Assmann Coagulation factor VII and the risk of coronary heart disease in healthy men Arterioscl. Thromb. Vasc. Biol. 17 1997 1539 1544
82. N. Yahia, and T.A. Sanders The influence of dietary fat on postprandial lipaemia and factor VII coagulant activity in human subjects Proc. Nutr. Soc. 56 1997 489 496
83. D. Girelli, C. Russo, P. Ferraresi, O. Olivieri, M. Pinotti, S. Friso, F. Manzato, A. Mazzucco, F. Bernardi, and R. Corrocher Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease N. Engl. J. Med. 343 2000 774 780
84. d.S. Carvalho, E. Bruckert, P. Giral, C. Soria, J. Chapman, J. Truffert, F. Dairou, J.L. De Gennes, and J.P. Caen Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity Haemostasis 19 1989 125 130
85. J.H. Griffin, J.A. Fernandez, and H. Deguchi Plasma lipoproteins, hemostasis and thrombosis Thromb. Haemost. 86 2001 386 394
86. A.S. Lindman, H. Muller, I. Seljeflot, H. Prydz, M. Veierod, and J.I. Pedersen Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor VII and serum choline-containing phospholipids Br. J. Nutr. 90 2003 329 336
87. D. Kirchhofer, C. Eigenbrot, M.T. Lipari, P. Moran, M. Peek, and R.F. Kelley The tissue factor region that interacts with factor Xa in the activation of factor VII Biochemistry 40 2001 675 682
88. J.C. Chan Gene targeting in hemostasis. Factor VII Front. Biosci. 6 2001 D98 D104
89. P. Golino The inhibitors of the tissue factor:factor VII pathway Thromb. Res. 106 2002 V257 V265
90. S.E. Humphries, A. Lane, S. Dawson, and F.R. Green The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1 Arch. Pathol. Lab. Med. 116 1992 1322 1329
91. M. Pinotti, R. Toso, D. Girelli, D. Bindini, P. Ferraresi, M.L. Papa, R. Corrocher, G. Marchetti, and F. Bernardi Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies Blood 95 2000 3423 3428
92. d.S. Carvalho, E. Bruckert, C. Soria, and J.P. Caen Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia Nouv. Rev. Fr. Hematol. 31 1989 13 15
93. D. Li, and A.J. Sinclair Plasma coagulation factor VII activity and its correlates in healthy men Asia Pac. J. Clin. Nutr. 12 Suppl 2003 S20
94. L.I. Mennen, E.G. Schouten, D.E. Grobbee, and C. Kluft Coagulation factor VII, dietary fat and blood lipids: a review Thromb. Haemost. 76 1996 492 499
95. A.R. Folsom, J. Ma, J.H. Eckfeldt, E. Shahar, and K.K. Wu Plasma phospholipid fatty-acid composition and factor-Vii coagulant activity Atherosclerosis 111 1994 199 207
96. A.R. Hubbard, and L.J. Parr The effect of phospholipase C on plasma factor VII Br. J. Haematol. 73 1989 360 364
97. K.A. Mitropoulos, G.J. Miller, B.E. Reeves, H.C. Wilkes, and J.K. Cruickshank Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men Atherosclerosis 76 1989 203 208
98. P.Y. Scarabin, L. Bara, M. Samama, and G. Orssaud Further evidence that activated factor VII is related to plasma lipids Br. J. Haematol. 61 1985 186 187
99. H.C. Simpson, J.I. Mann, T.W. Meade, R. Chakrabarti, Y. Stirling, and L. Woolf Hypertriglyceridaemia and hypercoagulability Lancet 1 1983 786 790
100. H.M. Roche, and M.J. Gibney Postprandial coagulation factor VII activity: the effect of monounsaturated fatty acids Br. J. Nutr. 77 1997 537 549
101. L.F. Larsen, E.M. Bladbjerg, J. Jespersen, and P. Marckmann Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscl. Thromb. Vasc. Biol. 17 1997 2904 2909
102. T.A. Sanders, T. de Grassi, G.J. Miller, and J.H. Morrissey Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII) Atherosclerosis 149 2000 413 420
103. T.A. Sanders, T. de Grassi, G.J. Miller, and S.E. Humphries Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism Am J. Clin. Nutr. 69 1999 220 225
104. A.S. Lindman, J.I. Pedersen, E.M. Hjerkinn, H. Arnesen, M.B. Veierod, I. Ellingsen, and I. Seljeflot The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene Thromb. Haemost. 91 2004 1097 1104
105. M.P. de Maat, F. Green, P. de Knijff, J. Jespersen, and C. Kluft Factor VII polymorphisms in populations with different risks of cardiovascular disease Arterioscl. Thromb. Vasc. Biol. 17 1997 1918 1923
106. K. Kain, A.J. Catto, J. Young, J. Bamford, J. Bavington, and P.J. Grant Coagulation factor VII activity, Arg/Gln353 polymorphism and features of insulin resistance in first-degree-relatives of South Asian patients with stroke Thromb. Haemost. 88 2002 954 960
107. L.I. Mennen, M.P. de Maat, G. Meijer, P. Zock, D.E. Grobbee, F.J. Kok, C. Kluft, and E.G. Schouten Postprandial response of activated factor VII in elderly women depends on the R353Q polymorphism Am. J. Clin. Nutr. 70 1999 435 438
108. X.L. Wang, J. Wang, R.M. McCredie, and D.E. Wilcken Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease Arterioscl. Thromb. Vasc. Biol. 17 1997 246 251
109. F.H. Herrmann, K. Wulff, K. Auberger, V. Aumann, F. Bergmann, K. Bergmann, E. Bratanoff, D. Franke, M. Grundeis, W. Kreuz, H. Lenk, H. Losonczy, B. Maak, G. Marx, C. Mauz-Korholz, H. Pollmann, M. Serban, A. Sutor, G. Syrbe, G. Vogel, N. Weinstock, E. Wenzel, and K. Wolf Molecular biology and clinical manifestation of hereditary factor VII deficiency Semin. Thromb. Hemost. 26 2000 393 400
110. F. Green, C. Kelleher, H. Wilkes, A. Temple, T. Meade, and S. Humphries A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals Arterioscler. Thromb. 11 1991 540 546
111. F. Bernardi, P. Arcieri, R.M. Bertina, F. Chiarotti, J. Corral, M. Pinotti, H. Prydz, M. Samama, P.M. Sandset, R. Strom, V.V. Garcia, and G. Mariani Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations Arterioscler. Thromb. Vasc. Biol. 17 1997 2548 2553
112. D. Green, M.A. Chamberlain, K.J. Ruth, A.R. Folsom, and K. Liu Factor VII, cholesterol, and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study Arterioscler. Thromb. Vasc. Biol. 17 1997 51 55
113. A. Hamsten, U. de Faire, G. Walldius, G. Dahlen, A. Szamosi, C. Landou, M. Blomback, and B. Wiman Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Lancet 2 1987 3 9
114. Y. Kozima, T. Urano, K. Serizawa, Y. Takada, and A. Takada Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity Thromb. Res. 70 1993 191 202
115. H. Oda, M. Ohno, and H. Ohashi Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease Adv. Perit. Dial. 16 2000 152 155
116. A. Asplund-Carlson, A. Hamsten, B. Wiman, and L.A. Carlson Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men Diabetologia 36 1993 817 825
117. S. Ye, F.R. Green, P.Y. Scarabin, V. Nicaud, L. Bara, S.J. Dawson, S.E. Humphries, A. Evans, G. Luc, and J.P. Cambou The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde, Thromb. Haemost. 74 1995 837 841
118. J.P. Ioannidis, E.E. Ntzani, T.A. Trikalinos, and D.G. Contopoulos-Ioannidis Replication validity of genetic association studies Nat. Genet. 29 2001 306 309
119. S. Butenas, C. van't Veer, and K.G. Mann "Normal" thrombin generation Blood 94 1999 2169 2178
120. A.K. Duttaroy Dietary components and human platelet activity Platelets 13 2002 67 75
121. S. Goto Understanding the mechanism of platelet thrombus formation under blood flow conditions and the effect of new antiplatelet agents Curr. Vasc. Pharmacol. 2 2004 23 32
122. A.K. Duttaroy, M.J. Gordon, C. Kelly, K. Hunter, L. Crosbie, T. Knight-Carpentar, and B.C. Williams Inhibitory effect of Ginkgo biloba extract on human platelet aggregation Platelets 10 1999 298 305
123. C.M. Nieuwenhuys, and G. Hornstra The effects of purified eicosapentaenoic and docosahexaenoic acids on arterial thrombosis tendency and platelet function in rats Biochim. Biophys. Acta 1390 1998 313 322
124. G.J. Nelson, P.S. Schmidt, G.L. Bartolini, D.S. Kelley, and D. Kyle The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans Lipids 32 1997 1129 1136
125. A.K. Duttaroy, T.K. Ray, and A.K. Sinha Prostacyclin Stimulation of the Activation of Blood-Coagulation Factor-X by Platelets Science 231 1986 385 388
126. D.A. Hyson, T.G. Paglieroni, T. Wun, and J.C. Rutledge Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men Clin. Appl. Thromb. Hemost. 8 2002 147 155
127. F.H. de Man, R. Nieuwland, L.A. van der, F. Romijn, A.H. Smelt, J.A. Gevers Leuven, and A. Sturk Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy Atherosclerosis 152 2000 407 414
128. J.R. Nofer, M. Tepel, B. Kehrel, S. Wierwille, M. Walter, U. Seedorf, W. Zidek, and G. Assmann Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia Circulation 95 1997 1370 1377
129. A.M. Turpeinen, J. Wubert, A. Aro, R. Lorenz, and M. Mutanen Similar effects of diets rich in stearic acid or trans-fatty acids on platelet function and endothelial prostacyclin production in humans Arterioscler. Thromb. Vasc. Biol. 18 1998 316 322
130. A.M. Turpeinen, A.M. Pajari, R. Freese, R. Sauer, and M. Mutanen Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man Thromb. Haemost. 80 1998 649 655
131. H. Salah-Uddin, M.J. Gordon, I. Ford, N.N. Tandon, M. Greaves, and A.K. Duttaroy Surface expression of fatty acid translocase (FAT/CD36) on platelets in myeloproliferative disorders and non-insulin dependent diabetes mellitus: effect on arachidonic acid uptake Mol. Cell. Biochem. 239 2002 203 211
132. A.K. Duttaroy, and A.K. Sinha Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets J. Biol. Chem. 262 1987 12685 12691
133. G.J. Miller Dietary fatty acids and blood coagulation Prostaglandins Leukot. Essent. Fatty Acids 57 1997 389 394
134. A.K. Duttaroy Insulin-mediated processes in platelets, erythrocytes and monocytes macrophages - effects of essential fatty-acid metabolism Prostaglandins Leukot. Essent. Fatty Acids 51 1994 385 399
135. E.H.M. Temme, R.P. Mensink, and G. Hornstra Effects of diets enriched in lauric, palmitic or oleic acids on blood coagulation and fibrinolysis Thromb. Haemost. 81 1999 259 263